105 related articles for article (PubMed ID: 10232581)
1. Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers.
Gil J; Yamamoto H; Zapata JM; Reed JC; Perucho M
Cancer Res; 1999 May; 59(9):2034-7. PubMed ID: 10232581
[TBL] [Abstract][Full Text] [Related]
2. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
4. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.
Yamamoto H; Sawai H; Perucho M
Cancer Res; 1997 Oct; 57(19):4420-6. PubMed ID: 9331106
[TBL] [Abstract][Full Text] [Related]
5. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.
Brimmell M; Mendiola R; Mangion J; Packham G
Oncogene; 1998 Apr; 16(14):1803-12. PubMed ID: 9583678
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
7. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
Oncogene; 1999 Oct; 18(41):5703-13. PubMed ID: 10523849
[TBL] [Abstract][Full Text] [Related]
8. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
[TBL] [Abstract][Full Text] [Related]
10. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
[TBL] [Abstract][Full Text] [Related]
12. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
13. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2005 Apr; 26(4):713-23. PubMed ID: 15661804
[TBL] [Abstract][Full Text] [Related]
14. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
Chipuk JE; Kuwana T; Bouchier-Hayes L; Droin NM; Newmeyer DD; Schuler M; Green DR
Science; 2004 Feb; 303(5660):1010-4. PubMed ID: 14963330
[TBL] [Abstract][Full Text] [Related]
15. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
[TBL] [Abstract][Full Text] [Related]
16. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
17. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells.
von Haefen C; Wieder T; Gillissen B; Stärck L; Graupner V; Dörken B; Daniel PT
Oncogene; 2002 Jun; 21(25):4009-19. PubMed ID: 12037683
[TBL] [Abstract][Full Text] [Related]
18. Inactivating mutations of proapoptotic Bad gene in human colon cancers.
Lee JW; Soung YH; Kim SY; Nam SW; Kim CJ; Cho YG; Lee JH; Kim HS; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
Carcinogenesis; 2004 Aug; 25(8):1371-6. PubMed ID: 15033904
[TBL] [Abstract][Full Text] [Related]
19. Dimerization of mitochondrial Bax is associated with increased drug response in Bax-transfected A253 cells.
Guo B; Yin MB; Tóth K; Cao S; Azrak RG; Rustum YM
Oncol Res; 1999; 11(2):91-9. PubMed ID: 10489165
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival.
Beierle EA; Dai W; Iyengar R; Langham MR; Copeland EM; Chen MK
J Pediatr Surg; 2003 Mar; 38(3):486-91. PubMed ID: 12632373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
